II
This company develops universal influenza vaccines designed to prevent virus mutations. Their technology identifies invariant units within flu proteins to provide broad and efficient protection against viral diseases.
Updated 16 months ago
Funding
$255.9K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NS
Funding rounds are not available yet.
Founders
Product
Features
- This company develops universal influenza vaccines designed to prevent virus mutations. Their technology identifies invariant units within flu proteins to provide broad and efficient protection against viral diseases.